In a significant move within the healthcare and dental products sector, Patterson Companies, Inc. has announced its agreement to be acquired by Patient Square Capital, a prominent healthcare investment firm, for $31.35 per share in cash. This transaction values Patterson Companies at approximately $4.1 billion.

Strategic Acquisition: The acquisition follows a comprehensive review of strategic alternatives by Patterson's Board of Directors, supported by independent advisors. The deal aims to maximize Patterson's value and ensure the company's continued strategic execution into the future, according to Don Zurbay, President and CEO of Patterson Companies.

Future Outlook: The transaction is anticipated to finalize during the fourth quarter of Patterson's fiscal year 2025. Post-acquisition, Patterson will transition into a privately held entity, and its common shares will cease trading on the NASDAQ stock market.